Document is current
Any future updates will be listed below
-
Authors
Shafiekhani, Mojtaba https://orcid.org/0000-0001-8661-1838
Jafarzadeh, Mohammad Amin
Ahmadi, Mohammad https://orcid.org/0000-0002-6174-8907
Nikoupour, Hamed https://orcid.org/0000-0003-0708-334X
Shamsaeefar, Alireza https://orcid.org/0000-0003-3798-6064
Jafari, Keynoosh
Sohrabi Nazari, Sahar
Kafilzadeh, Kianaz
Gholami, Siavash
Zarei, Edalat
Kazemi, Kourosh
Sabzvari, Araz
Hosseini, Seyed Ali Malek https://orcid.org/0000-0002-0853-9938
Nikeghbalian, Saman https://orcid.org/0000-0003-4530-8829
- License Information
-
More Information
Article History
Received: 17 February 2025
Accepted: 14 August 2025
First Online: 24 October 2025
Declarations
:
: Informed consent was provided from all patients prior to participation, with the option to withdraw at any point during the study. Ethical approval was granted by the Shiraz University of Medical Sciences Regional Ethics Board (IR.SUMS.REC.1400.308).
: The trial was registered in the Iranian Registry of Clinical Trials under the identifier IRCT20150303021315N25.
: All authors declare no conflict of interest other than financial support of the study by CinnaGen® Company. CinnaGen® Company financially supported this study. The sponsor had no role in the study design or the collection, analysis, asnd interpretation of data, writing of the report, or decision to submit the article for publication.
